Respiratory Pathogen Panel by PCR (BioFire RP2.1) - Laboratory Technical Bulletin
Customize your policy alerts
Sign up for all mclaren health plan policy alerts
Know when mclaren health plan releases new policies or updates existing guidance.
Monitor payer policy activity
Announces verification and implementation of a new multiplex PCR respiratory pathogen panel (BioFire RP2.1) performed on nasopharyngeal specimens; describes organisms detected, specimen requirements, and operational/ordering notes for clinicians and laboratory staff within McLaren facilities.
A new test, Respiratory Pathogen Panel by PCR (BioFire RP2.1), has been verified and implemented effective November 19, 2024.
The BioFire RP2.1 assay identifies 19 viral and bacterial respiratory pathogens and subtypes.
Specimen collection, storage, and transport requirements for nasopharyngeal swabs are specified (volume, temperatures, and acceptable durations).
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.